Biotest AG (XTER:BIO)

€ 41 0 (0%) Market Cap: 1.34 Bil Enterprise Value: 1.83 Bil PE Ratio: 7.95 PB Ratio: 3.07 GF Score: 68/100

Q4 2022 Biotest AG Earnings Call Transcript
Mar 23, 2023

€42.9 (-0.46%)

Earnings
Q3 2022 Biotest AG Earnings Call Transcript
Nov 14, 2022

€42.9 (+0.47%)

Earnings
Q4 2021 Biotest AG Earnings Call Transcript
Mar 24, 2022

€42.1 (-1.64%)

Earnings
Q3 2021 Biotest AG Earnings Call Transcript
Nov 11, 2021

€43.2

Earnings
Grifols SA to Announce A Transformational Investment in Biotest AG Call Transcript
Sep 17, 2021
Q4 2020 Biotest AG Earnings Call Transcript
Mar 31, 2021

€30.6 (+1.32%)

Earnings
Nine Months 2020 Biotest AG Earnings Call Transcript
Nov 12, 2020

€26.6 (+3.10%)

Earnings
Full Year 2019 Biotest AG Earnings Call Transcript
Apr 01, 2020

€20 (+11.11%)

Earnings
Nine Months 2019 Biotest AG Earnings Call Transcript
Nov 14, 2019

€21.6 (-2.26%)

Earnings

Grifols SA to Announce A Transformational Investment in Biotest AG Call Transcript

Sep 17, 2021 / 09:00AM GMT

Release Date Price: €43.8 (+24.79%)

Transcript

Victor Grifols

Grifols USA, LLC - CEO of Grifols S.A., President of Grifols S.A and Director

And very good commercial footprint, very complementary to Grifols in the sense that they are not present in the U.S., we are very strong. And they have a stronger presence in some regions in the EMEA region, which is extremely complementary, both companies.

Brief description of Biotest number. This is public data, so I will not extend much. I have said, and Raimon have said, it's a family origin company founded in 1946. They have 2 manufacturing sites, one already for many years working around 1.5 million liters of plasma per year that it can process. And just -- it's about to finish an expansion of a new plant in the same site for additional 1.5 million liters. So in total, this new combination will give 3 million liters of additional manufacturing plasma throughput capacity per year, plus the 26 centers that I have just mentioned. And last, of course, but not least, Biotest, it's an entity that around -- has around 2,000 employees overall. And you see here the projections. The last actual data for

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.